CTS Chemical Industries is the CTS Group’s ‘state-of-the-art’ pharmaceutical plant in Kiryat Malachi. This plant, completely modernized in the early 2000s, covers 6500 m2 and is noted for its high quality, rapid throughput and adaptability to customized manufacturing
Modern and flexible production
The plant has all the facilities required to manufacture and test products according to specific customer needs. All stages of production – processing, packaging, storage and shipping - are fully integrated and are also supported by our on-site laboratories.
We produce a wide range of pharmaceuticals that include our own generic drugs, branded generics and products manufactured in Israel under international know-how agreements with Sanofi-Aventis, Vifor, Ethypharm, Mitsubishi Pharma and others.
Over 100 pharmaceutical products are produced in a variety of dosage forms:
- Solids: tablets, lozenges, caplets and capsules
- Liquids: syrups, drops and suspensions
Highly skilled personnel
CTS employees are highly educated. We invest continuously in our staff, giving them on-the-job training and updating them about the latest regulatory requirements and technological developments. Consequently they apply highly developed skills to ensure that CTS-manufactured products meet the highest quality expectations.
Adherence to international standards
Our products have a proud history of excellence in regulatory compliance. CTS Chemical Industries has GMP and ISO certificates from the following organizations:
TGA (Australian Health Authority) Certification
GMP Israeli Ministry of Health Certificate (MOH)
GMP of the PICs organization (representing 27 countries that include Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Malaysia, Netherlands, Norway, Switzerland and the UK)
ISO 9001 2000 of the Israel Standards Institute
ISO 14001 2004 of the Israel Standards Institute
OHSAS 18001 2007 of the Israel Standards Institute